| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |